BE904595A - Nouveaux derives naphtaleniques a action de type retinoide, leur procede de preparation et compositions medicamenteuse et cosmetique les contenant. - Google Patents
Nouveaux derives naphtaleniques a action de type retinoide, leur procede de preparation et compositions medicamenteuse et cosmetique les contenant.Info
- Publication number
- BE904595A BE904595A BE0/216529A BE216529A BE904595A BE 904595 A BE904595 A BE 904595A BE 0/216529 A BE0/216529 A BE 0/216529A BE 216529 A BE216529 A BE 216529A BE 904595 A BE904595 A BE 904595A
- Authority
- BE
- Belgium
- Prior art keywords
- preparation
- medicinal
- compositions containing
- cosmetic compositions
- alkyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/008—Preparations for oily skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
- C07C33/18—Monohydroxylic alcohols containing only six-membered aromatic rings as cyclic part
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
- C07C45/46—Friedel-Crafts reactions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C47/00—Compounds having —CHO groups
- C07C47/20—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms
- C07C47/228—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms containing six-membered aromatic rings, e.g. phenylacetaldehyde
- C07C47/232—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms containing six-membered aromatic rings, e.g. phenylacetaldehyde having unsaturation outside the aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C47/00—Compounds having —CHO groups
- C07C47/20—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms
- C07C47/26—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms containing hydroxy groups
- C07C47/27—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms containing hydroxy groups containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C47/00—Compounds having —CHO groups
- C07C47/20—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms
- C07C47/277—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
- C07C49/213—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing six-membered aromatic rings
- C07C49/217—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing six-membered aromatic rings having unsaturation outside the aromatic rings
- C07C49/223—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing six-membered aromatic rings having unsaturation outside the aromatic rings polycyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
- C07C49/24—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing hydroxy groups
- C07C49/245—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing hydroxy groups containing six-membered aromatic rings
- C07C49/248—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing hydroxy groups containing six-membered aromatic rings having unsaturation outside the aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
- C07C49/255—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
- C07C57/42—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings having unsaturation outside the rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/02—Preparations for cleaning the hair
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Birds (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Cosmetics (AREA)
Abstract
Composé de formule où R1 à R4 représentent indépendamment H, OH, alkyle en C1-C6 ou alcoxy en C1-C6; et A -COR5, R5 étant H lorsqu'au moins un des substituants R1 à R4 est différent de H; alkyle en C1-C6; amino ; (C1-C6) alkylamino; di(C1-C6) alkylamino; arylamino ; benzylamino; amino dérivant d'une amine cyclique ou hétérocyclique ; (-COR5 pouvant, etre la fonction amide d'un amino-acide ou d'une glucosamine) ou bien R5 représente -OR6, R6 étant H, (C1-C6)alkyle ; mono-ou polyhydroxyalkyle en C1-C6 aryle ou benzyle, éventuellement substitués ; -OR6 pouvant etre dérivé d'un sucre; et les sels et isomères de ce composé. Procédé de préparation de ce composé.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8505606A FR2580277B1 (fr) | 1985-04-15 | 1985-04-15 | Nouveaux derives naphtaleniques a action retinoique, le ur procede de preparation et compositions medicamenteuse et cosmetique les contenant |
Publications (1)
Publication Number | Publication Date |
---|---|
BE904595A true BE904595A (fr) | 1986-10-15 |
Family
ID=9318210
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE0/216529A BE904595A (fr) | 1985-04-15 | 1986-04-15 | Nouveaux derives naphtaleniques a action de type retinoide, leur procede de preparation et compositions medicamenteuse et cosmetique les contenant. |
Country Status (11)
Country | Link |
---|---|
US (1) | US4879284A (fr) |
JP (1) | JP2733656B2 (fr) |
BE (1) | BE904595A (fr) |
CH (1) | CH671395A5 (fr) |
DE (2) | DE3690187C2 (fr) |
FR (1) | FR2580277B1 (fr) |
GB (1) | GB2185253B (fr) |
IT (1) | IT1203552B (fr) |
NL (1) | NL193981C (fr) |
SE (2) | SE468986B (fr) |
WO (1) | WO1986006064A1 (fr) |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7655699B1 (en) | 1992-04-22 | 2010-02-02 | Eisai Inc. | Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors |
JP2594409B2 (ja) * | 1992-09-29 | 1997-03-26 | アディール エ コンパニー | トリエン側鎖を有する新規クロメン化合物 |
US7115728B1 (en) | 1995-01-30 | 2006-10-03 | Ligand Pharmaceutical Incorporated | Human peroxisome proliferator activated receptor γ |
EP0873295B1 (fr) | 1995-10-06 | 2003-04-02 | Ligand Pharmaceuticals, Inc. | Modulateurs rxr selectifs pour les dimeres et leurs methodes d'utilisation |
AU8588798A (en) * | 1997-07-25 | 1999-02-16 | Institut Pasteur | Human peroxisome proliferator activated receptor gamma (ppargamma) gene re gulatory sequences and uses therefor |
EP1033969A1 (fr) * | 1997-09-11 | 2000-09-13 | Smithkline Beecham Plc | Compositions adaptees pour un sejour prolonge dans le rhino-pharynx |
WO1999063980A1 (fr) * | 1998-06-12 | 1999-12-16 | Ligand Pharmaceuticals Inc. | Traitement du cancer du sein resistant aux anti-oestrogenes avec des modulateurs de rxr |
JP2003508397A (ja) | 1999-08-27 | 2003-03-04 | リガンド・ファーマシューティカルズ・インコーポレイテッド | アンドロゲンレセプターモジュレーターとしての8−置換−6−トリフルオロメチル−9−ピリド[3,2−g]キノリン化合物 |
EP1212330B1 (fr) | 1999-08-27 | 2006-04-19 | Ligand Pharmaceuticals Incorporated | Composes de modulation du recepteur androgene et procedes d'utilisation |
US6566372B1 (en) * | 1999-08-27 | 2003-05-20 | Ligand Pharmaceuticals Incorporated | Bicyclic androgen and progesterone receptor modulator compounds and methods |
CO5200852A1 (es) | 1999-09-14 | 2002-09-27 | Lilly Co Eli | Moduladores rxr con mejorado perfil farmacologico ceptores x de los retinoides |
JP2003040763A (ja) * | 2001-05-23 | 2003-02-13 | Taisho Pharmaceut Co Ltd | 多価アルコール含有軟膏剤基剤 |
DE10216005A1 (de) | 2002-04-11 | 2003-10-30 | Max Planck Gesellschaft | Verwendung von biologischen Photorezeptoren als direkt lichtgesteuerte Ionenkanäle |
US9050310B2 (en) * | 2004-06-25 | 2015-06-09 | Minas Theodore Coroneo | Treatment of ocular lesions |
US20060204474A1 (en) * | 2005-02-25 | 2006-09-14 | Coroneo Minas T | Treatment of epithelial layer lesions |
US10052497B2 (en) | 2005-07-22 | 2018-08-21 | The Board Of Trustees Of The Leland Stanford Junior University | System for optical stimulation of target cells |
US8926959B2 (en) | 2005-07-22 | 2015-01-06 | The Board Of Trustees Of The Leland Stanford Junior University | System for optical stimulation of target cells |
US20090093403A1 (en) | 2007-03-01 | 2009-04-09 | Feng Zhang | Systems, methods and compositions for optical stimulation of target cells |
US20070053996A1 (en) | 2005-07-22 | 2007-03-08 | Boyden Edward S | Light-activated cation channel and uses thereof |
US9274099B2 (en) | 2005-07-22 | 2016-03-01 | The Board Of Trustees Of The Leland Stanford Junior University | Screening test drugs to identify their effects on cell membrane voltage-gated ion channel |
US9238150B2 (en) | 2005-07-22 | 2016-01-19 | The Board Of Trustees Of The Leland Stanford Junior University | Optical tissue interface method and apparatus for stimulating cells |
WO2008086470A1 (fr) | 2007-01-10 | 2008-07-17 | The Board Of Trustees Of The Leland Stanford Junior University | Système pour stimulation optique de cellules cibles |
WO2008101128A1 (fr) | 2007-02-14 | 2008-08-21 | The Board Of Trustees Of The Leland Stanford Junior University | Système, procédé et applications comprenant l'identification de circuits biologiques tels que des caractéristiques neurologiques |
US10035027B2 (en) | 2007-10-31 | 2018-07-31 | The Board Of Trustees Of The Leland Stanford Junior University | Device and method for ultrasonic neuromodulation via stereotactic frame based technique |
US10434327B2 (en) | 2007-10-31 | 2019-10-08 | The Board Of Trustees Of The Leland Stanford Junior University | Implantable optical stimulators |
WO2009131837A2 (fr) | 2008-04-23 | 2009-10-29 | The Board Of Trustees Of The Leland Stanford Junior University. | Systèmes, procédés et compositions permettant la stimulation optique de cellules cibles |
BRPI0913285A2 (pt) | 2008-05-29 | 2018-10-16 | Univ Leland Stanford Junior | linhagem celular, sistema e método para controle ótico de mensageiros secundários |
SG191593A1 (en) | 2008-06-17 | 2013-07-31 | Univ Leland Stanford Junior | Methods, systems and devices for optical stimulation of target cells using an optical transmission element |
BRPI0915583A2 (pt) | 2008-06-17 | 2016-01-26 | Univ Leland Stanford Junior | aparelho e métodos para controle do desenvolvimento celular |
US9101759B2 (en) | 2008-07-08 | 2015-08-11 | The Board Of Trustees Of The Leland Stanford Junior University | Materials and approaches for optical stimulation of the peripheral nervous system |
NZ602416A (en) | 2008-11-14 | 2014-08-29 | Univ Leland Stanford Junior | Optically-based stimulation of target cells and modifications thereto |
EP2547762B1 (fr) | 2010-03-17 | 2018-04-25 | The Board of Trustees of the Leland Stanford Junior University | Molécules laissant passer les ions sensibles à la lumière |
CA2816990A1 (fr) | 2010-11-05 | 2012-05-10 | The Board Of Trustees Of The Leland Stanford Junior University | Proteines opsine a fonction en escalier stabilisee et leurs procedes d'utilisation |
AU2011323228B2 (en) | 2010-11-05 | 2016-11-10 | The Board Of Trustees Of The Leland Stanford Junior University | Control and characterization of memory function |
ES2716819T3 (es) | 2010-11-05 | 2019-06-17 | Univ Leland Stanford Junior | Opsinas quiméricas activadas por luz y métodos de uso de las mismas |
CA3056186A1 (fr) | 2010-11-05 | 2012-05-10 | Board Of Trustees Of The Leland Stanford Junior University | Dysfonctionnement du snc controle optiquement |
CN106422081B (zh) | 2010-11-05 | 2019-06-21 | 斯坦福大学托管董事会 | 用于光遗传学方法的光的上转换 |
JP6355335B2 (ja) | 2010-11-05 | 2018-07-11 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー | 報酬関連行動の光遺伝学的制御 |
US8696722B2 (en) | 2010-11-22 | 2014-04-15 | The Board Of Trustees Of The Leland Stanford Junior University | Optogenetic magnetic resonance imaging |
CA2859364C (fr) | 2011-12-16 | 2019-05-07 | The Board Of Trustees Of The Leland Stanford Junior University | Polypeptides opsines et leurs procedes d'utilisation |
ES2628006T3 (es) | 2012-02-21 | 2017-08-01 | Circuit Therapeutics, Inc. | Composiciones para el tratamiento de trastornos neurogénicos del suelo pélvico |
US9636380B2 (en) | 2013-03-15 | 2017-05-02 | The Board Of Trustees Of The Leland Stanford Junior University | Optogenetic control of inputs to the ventral tegmental area |
JP6594854B2 (ja) | 2013-03-15 | 2019-10-23 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー | 行動状態の光遺伝学的制御方法 |
AU2014260101B2 (en) | 2013-04-29 | 2018-07-26 | Humboldt-Universitat Zu Berlin | Devices, systems and methods for optogenetic modulation of action potentials in target cells |
CA2921221A1 (fr) | 2013-08-14 | 2015-02-19 | The Board Of Trustees Of The Leland Stanford Junior University | Compositions et procedes pour reguler une douleur |
US10568516B2 (en) | 2015-06-22 | 2020-02-25 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and devices for imaging and/or optogenetic control of light-responsive neurons |
US11045441B2 (en) | 2015-10-13 | 2021-06-29 | Wisconsin Alumni Research Foundation | Use of retinoic acid and analogs thereof to treat central neural apneas |
US11294165B2 (en) | 2017-03-30 | 2022-04-05 | The Board Of Trustees Of The Leland Stanford Junior University | Modular, electro-optical device for increasing the imaging field of view using time-sequential capture |
CN110105213B (zh) * | 2019-06-06 | 2022-03-25 | 唐山师范学院 | 一种(e)-2-(萘基-1-氧甲基)-2-二辛烯酸-8-酯的合成方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3984444A (en) * | 1971-11-10 | 1976-10-05 | Hoechst Aktiengesellschaft | Isomerization process of a higher fatty acid ester having isolated double bonds |
CH582668A5 (fr) * | 1973-08-10 | 1976-12-15 | Hoffmann La Roche | |
LU77254A1 (fr) * | 1977-05-04 | 1979-01-18 | ||
DE3121091A1 (de) * | 1981-05-27 | 1983-08-18 | Henkel Kgaa | Topische, kosmetische zubereitungen zur behandlung von seborrhoe |
-
1985
- 1985-04-15 FR FR8505606A patent/FR2580277B1/fr not_active Expired
-
1986
- 1986-04-14 NL NL8620129A patent/NL193981C/nl not_active IP Right Cessation
- 1986-04-14 US US07/002,708 patent/US4879284A/en not_active Expired - Lifetime
- 1986-04-14 JP JP61502251A patent/JP2733656B2/ja not_active Expired - Lifetime
- 1986-04-14 DE DE3690187A patent/DE3690187C2/de not_active Expired - Lifetime
- 1986-04-14 WO PCT/FR1986/000123 patent/WO1986006064A1/fr active Application Filing
- 1986-04-14 GB GB8629758A patent/GB2185253B/en not_active Expired
- 1986-04-14 CH CH5070/86A patent/CH671395A5/fr not_active IP Right Cessation
- 1986-04-14 DE DE19863690187 patent/DE3690187T1/de active Pending
- 1986-04-15 IT IT67311/86A patent/IT1203552B/it active
- 1986-04-15 BE BE0/216529A patent/BE904595A/fr not_active IP Right Cessation
- 1986-11-14 SE SE8604875A patent/SE468986B/sv not_active IP Right Cessation
- 1986-11-14 SE SE8604875D patent/SE8604875L/xx not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
GB2185253B (en) | 1989-06-21 |
JP2733656B2 (ja) | 1998-03-30 |
IT1203552B (it) | 1989-02-15 |
DE3690187T1 (fr) | 1987-10-08 |
SE8604875D0 (sv) | 1986-11-14 |
GB8629758D0 (en) | 1987-01-21 |
NL8620129A (nl) | 1987-03-02 |
FR2580277B1 (fr) | 1988-06-10 |
NL193981C (nl) | 2001-04-03 |
DE3690187C2 (de) | 1998-11-26 |
WO1986006064A1 (fr) | 1986-10-23 |
JPS62502471A (ja) | 1987-09-24 |
CH671395A5 (fr) | 1989-08-31 |
NL193981B (nl) | 2000-12-01 |
SE468986B (sv) | 1993-04-26 |
SE8604875L (sv) | 1986-11-14 |
US4879284A (en) | 1989-11-07 |
GB2185253A (en) | 1987-07-15 |
FR2580277A1 (fr) | 1986-10-17 |
IT8667311A0 (it) | 1986-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BE904595A (fr) | Nouveaux derives naphtaleniques a action de type retinoide, leur procede de preparation et compositions medicamenteuse et cosmetique les contenant. | |
KR870000332A (ko) | 이미다조헤테로 사이클릭 화합물의 제조방법 | |
DK540485A (da) | Substituerede imidazolderivater samt fremgangsmaade til fremstilling deraf og forbindelsernes anvendelse | |
KR830007597A (ko) | 3-아릴-5-이소티아졸 유도체의 제조방법 | |
HUT38309A (en) | Process for preparing new prostaglandin derivatives and pharmaceutical compositions containing such active substance | |
IL84917A (en) | Quinolinone derivative,its preparation and pharmaceutical compositions containing it | |
EP0268377A3 (en) | Glutamic acid derivatives, processes and intermediates for their preparation and pharmaceutical formulations containing them | |
ES8704445A1 (es) | Procedimiento de preparar derivados aminicos | |
DK72686D0 (da) | Aminosyrederivat og antikonvulsant praeparat som indeholder derivatet | |
SE8605504D0 (sv) | Novel chroman derivatives | |
BE904316A (fr) | Procede de preparation d'ethers phenethyliques utilisant des intermediaires cycliques. | |
BE900275A (fr) | Azetidinones. | |
KR840006644A (ko) | 1,4-디히드로피리딘 유도체 및 그제법 | |
ES8702341A1 (es) | Un procedimiento para la produccion de un derivado de dia- midas de n-acilaminoacidos | |
KR850003539A (ko) | 밀베마이신 5-카르보네이트 유도체의 제조방법 | |
KR830009065A (ko) | 아미도-아미노산의 제조방법 | |
IE36116L (en) | N -(furylmethyl)morphinanes | |
ES8308834A1 (es) | Un procedimiento para la preparacion de derivados de etanolamina | |
GB1463282A (en) | Sugar ureide and thiooureide derivatives | |
ES8404311A1 (es) | Un procedimiento para la preparacion de derivados de etanolamina. | |
BE899937A (fr) | Nouveaux derives de la 1,4-dihydropyridine, leur preparation et leur utilisation comme medicaments. | |
PT73659A (en) | Ethenylimidazole derivatives with antimycotic activity processes for their preparation and pharmaceutical compositions containing them intermediates useful in their preparation and a process for the preparation thereof | |
BE902710A (fr) | Procede stereospecifique pour la preparation d'azetidinones. | |
GB1464431A (en) | Indolobenzazepine derivatives and a process for the manufacture thereof | |
US4507316A (en) | Antihypertensive compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RE20 | Patent expired |
Owner name: L *OREAL Effective date: 20060415 |